In the present study, we found for the first time that ILG ameliorated behavioral symptoms of PD and that this effect was achieved by promoting the Nrf2/NQO-1 signaling pathway to attenuate neuroinflammation. The gene discussed is NQO1; the disease is Parkinson disease.